Private equity and investment-services firm focused on alternative asset management and middle-market buyouts, with sponsor-backed and family-office capital deployment. Pinney & Scofield Inc. positions itself as a sector-agnostic investor targeting operationally intensive businesses in manufacturing, healthcare services and niche consumer brands, offering control and growth-oriented capital, board-level operational support and exit planning for strategic sales or recapitalizations.
Private equity and investment-services firm focused on alternative asset management and middle-market buyouts, with sponsor-backed and family-office capital deployment. Pinney & Scofield Inc. positions itself as a sector-agnostic investor targeting operationally intensive businesses in manufacturing, healthcare services and niche consumer brands, offering control and growth-oriented capital, board-level operational support and exit planning for strategic sales or recapitalizations.
Targets middle-market control investments in operationally intensive businesses across manufacturing, healthcare services and niche consumer brands. Emphasizes a hands-on private equity playbook: buy-and-build value creation, operational improvement, margin expansion and governance upgrades. Prefers sponsor-backed and family-office capital structures, flexible hold periods tied to execution of strategic exits or recapitalizations. Underwriting blends cashflow resilience, unit economics and management continuity; risk managed through concentrated portfolio construction, staged capital with operational KPIs, and active board-level involvement to accelerate EBITDA growth and liquidity creation.
Targets middle-market control investments in operationally intensive businesses across manufacturing, healthcare services and niche consumer brands. Emphasizes a hands-on private equity playbook: buy-and-build value creation, operational improvement, margin expansion and governance upgrades. Prefers sponsor-backed and family-office capital structures, flexible hold periods tied to execution of strategic exits or recapitalizations. Underwriting blends cashflow resilience, unit economics and management continuity; risk managed through concentrated portfolio construction, staged capital with operational KPIs, and active board-level involvement to accelerate EBITDA growth and liquidity creation.
| Trades 711 | Longs Won 509/711 71% | Profit Factor 34.18 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $630,203.38 |
| Average Win $112,530.38 | Best Trade (Mar 30) $11.75M | Sharpe Ratio -358.94 |
| Average Loss -$8,295.4 | Worst Trade (Oct 15) -$431,677.32 | Z-Score 12.58 (100%) |
| Commissions $0 | Avg. Trade Length 1y 1m 3w | Expectancy $78,202.94 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.02% |
| Consecutive Losing Trades | 25,000 | 22,500 | 20,000 | 17,500 | 15,000 | 12,500 | 10,000 | 7,500 | 5,000 | 2,500 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
| 5318 53184C118 | 2,500 | $27,350 | $27,350 | - | - | - | 0.0 |
AAPL Apple Inc. | 22,530 | $5.57M | $7.78M | - | $2.2M | 39.5% | +0.927% |
ABBV AbbVie Inc. | 478 | $87,221.82 | $135,919.3 | - | $48,697.48 | 55.83% | +0.335% |
ABT Abbott Laboratories | 132 | $13,552 | $13,780.8 | - | $228.8 | 1.69% | -0.267% |
ACB Aurora Cannabis Inc. | 400 | $1,700 | $1,594 | - | -$106 | -6.24% | -2.805% |
ADI Analog Devices, Inc. | 241 | $51,714.39 | $98,313.54 | - | $46,599.15 | 90.11% | +0.988% |
ADM Archer-Daniels-Midland Co | 500 | $36,345 | $41,465 | - | $5,120 | 14.09% | 0.0 |
ADP Automatic Data Processing Inc. | 450 | $131,729 | $129,233.25 | - | -$2,495.75 | -1.89% | +0.537% |
AEG Aegon N.V. | 714 | $4,205 | $5,979.75 | - | $1,774.75 | 42.21% | +1.27% |
AEVA Aeva Technologies, Inc. | 100 | $1,316 | $1,055 | - | -$261 | -19.83% | -4.047% |
AGG iShares Core U.S. Aggregate Bond ETF | 1,192 | $118,330 | $113,812.16 | - | -$4,517.84 | -3.82% | +0.073% |
AKAM Akamai Technologies Inc. | 225 | $21,317.85 | $19,874.25 | - | -$1,443.6 | -6.77% | -4.322% |
ALLO Allogene Therapeutics Inc. | 192 | $409 | $252.48 | - | -$156.52 | -38.27% | -1.866% |
AMD Advanced Micro Devices, Inc. | 262 | $39,181.47 | $142,195.26 | - | $103,013.79 | 262.91% | -3.468% |
AMGN Amgen Inc. | 200 | $62,276 | $87,250 | - | $24,974 | 40.1% | +0.511% |
AMT American Tower Corporation | 265 | $48,603.47 | $48,925.62 | - | $322.15 | 0.66% | +1.8% |
AMZN Amazon.com Inc | 2,260 | $489,995.29 | $573,068.2 | - | $83,072.91 | 16.95% | -0.467% |
ANET Arista Networks, Inc. | 30 | $3,683 | $5,403 | - | $1,720 | 46.7% | -2.953% |
ARM Arm Holdings plc American Depositary Receipt | 40 | $6,051 | $9,432 | - | $3,381 | 55.88% | -3.673% |
ASML ASML Holding N.V. New York Registry Shares | 5 | $3,465 | $8,321.42 | - | $4,856.42 | 140.16% | +0.413% |